Table 1 The risk score was associated with the Gleason score, T stage, and N stage of patients with PCa in the training set
Total (N = 404) | Expression | P-value | ||
|---|---|---|---|---|
High_risk (N = 202) | Low_risk (N = 202) | |||
Gleason_Score | ||||
6 | 23 (5.7%) | 7 (3.5%) | 16 (7.9%) | 0.005 |
7 | 201 (49.8%) | 87 (43.1%) | 114 (56.4%) | |
8 | 57 (14.1%) | 32 (15.8%) | 25 (12.4%) | |
9 | 120 (29.7%) | 74 (36.6%) | 46 (22.8%) | |
10 | 3 (0.7%) | 2 (1.0%) | 1 (0.5%) | |
Age (years) | ||||
> = 55 | 62 (15.3%) | 25 (12.4%) | 37 (18.3%) | 0.129 |
< 55 | 342 (84.7%) | 177 (87.6%) | 165 (81.7%) | |
pT | ||||
T2 | 140 (34.7%) | 50 (24.8%) | 90 (44.6%) | < 0.001 |
T3 | 254 (62.9%) | 144 (71.3%) | 110 (54.5%) | |
T4 | 10 (2.5%) | 8 (4.0%) | 2 (1.0%) | |
pN | ||||
N0 | 330 (81.7%) | 150 (74.3%) | 180 (89.1%) | < 0.001 |
N1 | 74 (18.3%) | 52 (25.7%) | 22 (10.9%) | |